Provider review
The $149 it advertises everywhere is a first month, not a rate.
Alinwell's homepage, its program cards and its sticky offer bar all say "from $149/mo" for semaglutide and "from $199/mo" for tirzepatide. Its checkout labels those exact figures "$100 off first month" and prints $249 and $299 struck through beside them.
Reviewed by Marcus Webb
This review's stake, stated plainly — some of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
At a glance
Visit AlinwellPharmacy
Not categorized
Labs
Not published as a requirement, cost or cadence.
States
Not stated
Ranked on this board
Care Bare Rx
Tells you exactly what you're buying — but $199 is a starting point, not a rate.
#1 on our tirzepatide provider ranking. Alinwell is not ranked on it — we have read what it publishes, not placed it in an order.
Read the Care Bare Rx review →What this price covers
Medication
Included
Provider visits
Included
Shipping
Not confirmed
Lab work
Not disclosed
Coaching
Not confirmed
The catch — The advertised figure is an introductory month. Alinwell's checkout labels $149 as "$100 off first month" and strikes $249 beside it; tirzepatide does the same at $199 against $299. Anyone budgeting from the homepage is $100 a month short from month two onward. The three-month plan is the same trap from the other side: at $219 a month it is marketed as the most popular choice while costing more per month than the $149 the site advertises.
See plans at AlinwellPrices read from Alinwell's own site · September 2026
What they advertise
"FROM $149/MO" for compounded semaglutide and "FROM $199/MO" for tirzepatide, repeated on the homepage, the program grid and a sticky new-patient bar. A GLP-1 microdose is advertised from $149. Its treatment pages themselves carry no price at all — only the words "AVAILABLE BY CONSULTATION".
What you actually pay
$249/mo compounded semaglutide and $299/mo compounded tirzepatide, charged every 30 days. The advertised $149 and $199 are first months. A microdose is $149/mo and an unadvertised oral GLP-1 is $150/mo, each on a single plan with no discount tier. Committed tiers run $219 and $189 a month for semaglutide at three and six months, and $269 and $239 for tirzepatide.
Money you will meet later
Alinwell is a Southlake, Texas telehealth service aimed at women, selling compounded semaglutide, compounded tirzepatide, a GLP-1 microdose and a nineteen-item peptide line. It does two things better than most providers here: it publishes certificates of analysis for its medications, and those certificates name the pharmacies compounding them — Emerald Compounding Pharmacy in Tampa and Boudreaux's New Drug Store in Lake Charles — which nothing in its own copy does. The problem is the number. From the homepage to the offer bar, every surface says $149 a month, and $149 is what you pay once. The standing rate is $249 for semaglutide and $299 for tirzepatide, and the only place either appears is a checkout screen thirty-one questions deep.
Alinwell is not ranked on any of our boards. This is a standalone read of what the company publishes about itself — the providers we do rank in this category are on our tirzepatide provider ranking. Nothing on this page is a performance claim.
Alinwell does not name the pharmacy that fills your prescription.
Not named in a single sentence of Alinwell's own copy — but named in the certificates of analysis its treatment pages link from a visible button. Those documents name Emerald Compounding Pharmacy of Tampa, Florida and Boudreaux's New Drug Store of Lake Charles, Louisiana for the two GLP-1s, and Greenwich Rx and ViOS for the peptide line. The site never says which pharmacy fills a given order, and the terms 503A and 503B do not appear anywhere on it, so no regulatory category attaches to any of the four. The certificates also disclose something the product copy does not: both GLP-1s are compounded with glycine.
A 503A pharmacy compounds for one named patient; a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Compounded peptides are not FDA-approved.
Its FAQ says the service is available across all 50 states and its About page prints a counter reading 50 states served, while its contact page says only that Alinwell operates in the states where it is licensed. The intake's own state list offers 51 jurisdictions — the 50 states plus the District of Columbia. No list is published in prose.
The part they would rather you skipped
Every public price on Alinwell's website is a first-month price presented as a monthly rate. "FROM $149/MO" appears in the hero, in the program grid, in the BMI estimator block and in a sticky bar that follows you down the page, and the treatment pages that would settle it print no figure at all — just the words "AVAILABLE BY CONSULTATION". The real rate surfaces once, on a checkout screen thirty-one questions into the intake, where the same $149 is labeled "$100 off first month" with $249 struck through next to it. Tirzepatide runs the same way at $199 against $299. That structure also breaks the site's own upsell: the three-month plan it badges MOST POPULAR costs $219 a month, which is $70 more per month than the price the whole site advertises. And the screen before the checkout congratulates you — "Woohoo! You're Approved" — while the screen after it explains that a physician has not looked at your file yet.
None of this is unique to Alinwell — the whole category shares it.
The providers we rank on our tirzepatide provider ranking, in the order that board ranks them. Alinwell is not among them: it is reviewed here, not ranked there, and we would rather show you the comparison than pretend the two are the same thing.
140 more providers rank on our tirzepatide provider ranking — see the full ranking. Every provider we review →
A provider comparison is half the decision. The other half is whether the compound does anything for you at all. The evidence below is where that gets settled.
Ready to get started?
Prices and plans in this category change often — check Alinwell's current pricing before you decide. Ours was read from their own site in September 2026.
Facts on this page reflect Alinwell's own public disclosures when we last checked them, in September 2026. Prices and terms change without notice — confirm on Alinwell's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved. See our disclosure and editorial policy.
Alinwell
See current pricing